[1]卢冠铭,黄照权,梁烨,等.中药对改善介入治疗肝癌患者凝血纤溶功能紊乱情况的研究[J].西部中医药,2013,26(07):1-4.
　LU Guanming,HUANG Zhaoquan,LIANG Ye,et al.Study on TCM Improving Cruor-fibrinolysis Disorders of Liver Cancer Patients Given with Interventional Therapy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):1-4.
点击复制

中药对改善介入治疗肝癌患者凝血纤溶功能紊乱情况的研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年07期
页码:
1-4
栏目:
出版日期:
2013-07-15

文章信息/Info

Title:
Study on TCM Improving Cruor-fibrinolysis Disorders of Liver Cancer Patients Given with Interventional Therapy
文章编号:
1004-6852(2013)07-0001-04
作者:
卢冠铭，黄照权，梁烨，李天资△，陈永诚 陆高翔，蓝家富，李清锋
右江民族医学院临床学院腺体外科，广西 百色 533000
Author(s):
LU Guanming, HUANG Zhaoquan, LIANG Ye, LI Tianzi△, CHEN Yongcheng, LU Gaoxiang, LAN Jiafu, LI Qingfeng
Surgical Department of Glands in Clinical School of Youjiang Medical University for Nationality, Baise 533000, China
关键词:
肝细胞癌; 原发性; 血栓前状态; 中药治疗
Keywords:
hepatocellular carcinoma;  primary;  prethrombotic state;  TCM therapy
分类号:
R735.7
文献标志码:
A
摘要:
目的：探讨中药改善介入治疗肝癌患者凝血纤溶紊乱功能的情况。方法：给予介入治疗的20例原发性肝细胞癌(HCC)患者中药治疗，于治疗前后检测患者血浆凝血酶原时间（PT）、部分凝血活酶时间（APTT）、凝血酶时间（TT）、纤维蛋白原含量（FIB）、P-选择素（Ps）、血管性血友病因子（vWF）、尿激酶型纤溶酶原激活物(uPA)和检测纤溶酶原激活物抑制物(PAI)水平，并与单纯介入治疗的20例原发性肝细胞癌（HCC）和10例健康组比较。结果：与治疗前比较，治疗组患者PT、APTT、TT和FIB水平均有好转（P＜0.01或P＜0.05），对照组PT、APTT、TT和FIB水平均无好转（P＞0.05）；治疗后与健康组比较，治疗组患者PT、APTT、TT和FIB水平已经达到正常组的平均水平（P＞0.05），对照组PT、APTT、TT和FIB水平均未达到正常组的平均水平（P＜0.01）。与治疗前比较，治疗组患者Ps、vWF、uPA和PAI水平均有好转（P＜0.05），对照组uPA水平有好转（P＜0.01）；治疗后与健康组比较，治疗组患者Ps、vWF和PAI水平已经达到正常组的平均水平（P＞0.05），对照组Ps、vWF、uPA和PAI水平均未达到正常组的平均水平（P＜0.01或P＜0.05）。结论:中药可改善介入治疗HCC患者凝血纤溶功能紊乱，预防血栓形成，促进康复。
Abstract:
Objective: To explore the state of TCM improving cruor-fibrinolysis disorders of liver cancer patients who received interventional therapy. Method: Twenty patients with hepatocellular carcinoma(HCC) who received interventional therapy took herbs. Plasma prothrombin time(PT), partial thromboplastin time (APTT), thrombin time(TT), the contents of fibrinogen(FIB), P-selectin (Ps), von willebrand factor (vWF), urokinase-type plasminogen activator(uPA) and level of plasminogen activator inhibitor(PAI) were tested before and after the treatment, those indexes were compared with those of twenty patients received single interventional therapy and ten cases in the healthy group. Result: The levels of PT, APTT, TT and FIB of the patients in the treatment group were improved compared with those before treating(P＜0.01 or P＜0.05), the levels of PT, APTT, TT and FIB in the patients of the control group were unchanged(P＞0.05); PT, APTT, TT and FIB of the patients after treating have reached to the average levels of the normal group compared with the healthy group(P＞0.05), those indexes of the patients in the control group haven't been to average levels of the normal group(P＜0.01). The levels of Ps, vWF, uPA and PAI of the patients in the treatment group were improved compared with those before treating(P＜0.05), the level of uPA of the control group was improved(P＜0.01). Compared with the healthy group, Ps, vWF and PAI of the patients of the treatment group have already been to average level of the normal group (P＞0.05), those indexes of the control group haven't been to average levels of the normal group(P＜0.01 or P＜0.05). Conclusion: TCM could improve the cruor-fibrinolysis disorders of liver cancer patients who received interventional therapy, effectively prevent the thrombogenesis and promote the rehabilitation.

相似文献/References:

[1]谷云,李小梅,潘耀军,等.吴克明教授治疗虚寒型原发性痛经的经验[J].西部中医药,2011,24(11):14.
[2]王兆勤.中西医结合治疗女大学生原发性痛经55例临床观察[J].西部中医药,2013,26(01):91.
　WANG Zhaoqin.Clinical Observation on Integrated Traditional Chinese and Western Medicine in Treating 55 Cases of Primary Dysmenorrhea in Undergraduate Students[J].Western Journal of Traditional Chinese Medicine,2013,26(07):91.
[3]刘丽萍.四物汤合失笑散加味联合吲哚美辛治疗气滞血瘀型原发性痛经40例[J].西部中医药,2013,26(03):103.
　LIU Liping.Modified SiW uTang and ShiXiaoSan Combined with Indomatacin in Treating 40 Cases of Primary Dysmenorrhea of Qi Stagnation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(07):103.
[4]冯建鹏.舒脉降压汤联合倍他乐克治疗高血压的临床观察[J].西部中医药,2012,25(05):8.
　FENG Jian-peng.Clinical Observation on ShuMai JiangYaTang and Metoprolol in Treating Hypertension[J].Western Journal of Traditional Chinese Medicine,2012,25(07):8.
[5]邓向花,曹亚,徐玲亚,等.循证护理对原发性闭角型青光眼手术患者心理健康和睡眠质量的影响[J].西部中医药,2014,27(10):133.
[6]李福荣.六味地黄汤联合激素治疗原发性肾病综合征30例[J].西部中医药,2014,27(12):89.
[7]夏湘君,曹亚,徐玲亚,等.循证护理应用于原发性闭角型青光眼患者的效果观察[J].西部中医药,2014,27(12):126.
[8]谢栋,陈大军,马国亮,等.原发性骨质疏松症的骨密度与中医脏腑辨证的相关性研究*[J].西部中医药,2015,28(02):82.
[9]曹军英.纽曼护理对原发性肝癌介入治疗患者焦虑和生活质量的影响[J].西部中医药,2015,28(04):140.
[10]陈岚.社区随访管理对原发性高血压患者疾病知晓率、服药率、控制率的影响[J].西部中医药,2015,28(06):145.[doi:2015/6/16 0:00:00]

备注/Memo

备注/Memo:
收稿日期：2012-12-14 *基金项目：国家自然科学基金(编号81060028)，广西科技攻关计划基金(编号桂科攻1355005-3-7)，广西卫生厅科学基金(编号Z2010092，Z2010474，Z2010086) 作者简介：卢冠铭(1979—)，男，在职博士研究生，副主任医师。研究方向：肝癌介入治疗的疗效机制与安全性。 △通讯作者：李天资(1956—)，男，研究员。研究方向：肝癌介入治疗的疗效机制与安全性。
更新日期/Last Update: 2013-07-15